This is the first meta-analysis that focuses on the effect of MSC on LN and renal function of patients with SLE, and the results shows a favorable safety profile and encouraging results of MSC for improving the disease activity of LN as well as the renal function of SLE patients.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- systematic review
- ankylosing spondylitis
- end stage renal disease
- mesenchymal stem cells
- ejection fraction
- newly diagnosed
- juvenile idiopathic arthritis
- peritoneal dialysis
- prognostic factors
- meta analyses
- stem cells
- patient reported outcomes
- case control
- patient reported